Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Lebovitz

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|March 25, 1995
Diabetic ketoacidosisH E Lebovitz
Pharmacotherapy|March 1, 1985
Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical useH E Lebovitz
Pediatric Clinics of North America|June 1, 1984
Etiology and pathogenesis of diabetes mellitusH E Lebovitz
Diabetes Care|July 1, 1988
Keeping tabs on oral agentsH E Lebovitz
The Journal of Clinical Psychiatry|January 25, 2002
Diagnosis, classification, and pathogenesis of diabetes mellitusH E Lebovitz
The American Journal of Cardiology|September 29, 2001
IntroductionH E Lebovitz
Hospital Practice (Office Ed.)|February 1, 1992
Are oral hypoglycemic agents likely to benefit NIDDM patients? AffirmativeH E Lebovitz
Diabetes Care|December 1, 1994
Stepwise and combination drug therapy for the treatment of NIDDMH E Lebovitz
Endocrinology and Metabolism Clinics of North America|December 1, 2001
Oral therapies for diabetic hyperglycemiaH E Lebovitz
Diabetes Research and Clinical Practice|May 1, 1993
Insulin-mimetic and insulin-sensitizing drugsH E Lebovitz
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|March 25, 1995
Diabetic ketoacidosisH E Lebovitz
Pharmacotherapy|March 1, 1985
Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical useH E Lebovitz
Pediatric Clinics of North America|June 1, 1984
Etiology and pathogenesis of diabetes mellitusH E Lebovitz
Diabetes Care|July 1, 1988
Keeping tabs on oral agentsH E Lebovitz
The Journal of Clinical Psychiatry|January 25, 2002
Diagnosis, classification, and pathogenesis of diabetes mellitusH E Lebovitz
The American Journal of Cardiology|September 29, 2001
IntroductionH E Lebovitz
Hospital Practice (Office Ed.)|February 1, 1992
Are oral hypoglycemic agents likely to benefit NIDDM patients? AffirmativeH E Lebovitz
Diabetes Care|December 1, 1994
Stepwise and combination drug therapy for the treatment of NIDDMH E Lebovitz
Endocrinology and Metabolism Clinics of North America|December 1, 2001
Oral therapies for diabetic hyperglycemiaH E Lebovitz
Diabetes Research and Clinical Practice|May 1, 1993
Insulin-mimetic and insulin-sensitizing drugsH E Lebovitz
Pageof 15